Brian M. Stolz Insider Trading
Get free email notifications about insider trading for Brian M. Stolz.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Brian M. Stolz. Brian M. Stolz is a in Activision Blizzard, Inc. ($ATVI) and a Chief People Officer in Activision Blizzard, Inc. ($ATVI) and a EVP Administration & CHCO in Valeant Pharmaceuticals International, Inc. ($BVF) and a EVP and CHCO in Valeant Pharmaceuticals International, Inc. ($BVF) and a EVP, Administration & CHCO in Valeant Pharmaceuticals International, Inc. ($BVF) and a EVP, Administration and CHCO in Valeant Pharmaceuticals International, Inc. ($BVF) and a EVP,Administration&CHCO in Valeant Pharmaceuticals International, Inc. ($BVF) and a Chief Operating Officer in BridgeBio Pharma, Inc. ($BBIO).
Address: VALEANT PHARMACEUTICALS INTERNATIONAL,IN 7150 MISSISSAUGA ROAD MISSISSAUGA L5N 8M5 A6
Companies in which Brian M. Stolz is an Insider
Activision Blizzard, Inc.
Industry: SERVICES-PREPACKAGED SOFTWARE [7372]
Position of Brian M. Stolz:
Holdings: 242,886 shares
Current Value: $9,727,584
Latest Transaction: Aug 15 2019
$ATVI Market Capitalization: $29.50B
$ATVI Previous Close: $40.05
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Bausch Health Companies Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Brian M. Stolz: EVP, Administration & CHCO, EVP and CHCO, EVP Administration & CHCO, EVP, Administration and CHCO, EVP,Administration&CHCO
Holdings: 125,280 shares
Latest Transaction: Jun 24 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
BridgeBio Pharma, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Brian M. Stolz: Chief Operating Officer
Holdings: 25,167 shares
Latest Transaction: Aug 18 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Brian M. Stolz
Sentiment: All, ATVI, BVF, BBIO
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 18 2020 | BBIO | BridgeBio Pharma, ... | Stolz Brian M. | Chief Operating Off ... | Option Exercise | M | 0.00 | 1,595 | 0 | 23,937 | |
| Aug 18 2020 | BBIO | BridgeBio Pharma, ... | Stolz Brian M. | Chief Operating Off ... | Payment of Exercise | F | 28.53 | 552 | 15,749 | 24,615 | 25.2 K to 24.6 K (-2.19 %) |
| Aug 18 2020 | BBIO | BridgeBio Pharma, ... | Stolz Brian M. | Chief Operating Off ... | Buy | M | 0.00 | 1,595 | 0 | 25,167 | 23.6 K to 25.2 K (+6.77 %) |
| Jun 05 2020 | BBIO | BridgeBio Pharma, ... | Stolz Brian M. | Chief Operating Off ... | Option Exercise | A | 0.00 | 25,532 | 0 | 25,532 | |
| Jun 05 2020 | BBIO | BridgeBio Pharma, ... | Stolz Brian M. | Chief Operating Off ... | Option Exercise | A | 28.86 | 183,727 | 5,302,361 | 183,727 | |
| Dec 16 2019 | BBIO | BridgeBio Pharma, ... | Stolz Brian M. | Chief Operating Off ... | Option Exercise | A | 0.00 | 72,696 | 0 | 72,696 | |
| Nov 15 2019 | BBIO | BridgeBio Pharma, ... | Stolz Brian M. | Chief Operating Off ... | Option Exercise | A | 0.00 | 106,469 | 0 | 106,469 |